Astellas Pharma Inc: all 983 studies

Page 6 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive DisorderCompletedNCT01919008Phase 1
• Repeat Dose Tolerance Study of Regadenoson in Healthy SubjectsCompletedNCT01918995Phase 1
• Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and ItraconazoleCompletedNCT01913379Phase 1
• A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male SubjectsCompletedNCT01911741Phase 1
• Drug-drug Interaction Study With MDV3100 and a Cocktail of SubstratesCompletedNCT01911728Phase 1
• A Study to Explore the Routes of Elimination of MDV3100CompletedNCT01911715Phase 1
• Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male VolunteersCompletedNCT01908296Phase 1
• A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell TransplantCompletedNCT01903928Phase 2
• Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal DialysisCompletedNCT01903213
• Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive DisorderCompletedNCT01903200Phase 1
• Relative Bioavailability Study of Enzalutamide in Prostate Cancer PatientsCompletedNCT01902251Phase 1
• Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control GroupCompletedNCT01901133Phase 1
• Long-Term Specified Drug Use-results Survey of Betanis TabletsCompletedNCT01901120
• Post-marketing Surveillance of Kiklin Capsules in Hemodialysis PatientsCompletedNCT01901107
• Specified Drug Use-results Survey of Betanis TabletsCompletedNCT01898624
• A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference DrugCompletedNCT01888445Phase 2
• Specified Drug Use-Results Survey of RegniteCompletedNCT01887613
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of MethotrexateCompletedNCT01884636Phase 1
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of MetforminCompletedNCT01884558Phase 1
• A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant SubjectsCompletedNCT01882322Phase 4
• Celecoxib Japan Observational Study for the Patients With Acute PainCompletedNCT01876121
• Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency PatientsCompletedNCT01872039Phase 4
• Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing HemodialysisCompletedNCT01872026Phase 1
• Multiple Oral Administration of ASP7991 to Non-elderly Male SubjectsCompletedNCT01872013Phase 1
• Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy VolunteersCompletedNCT01871987Phase 1
• Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive DisorderCompletedNCT01871974Phase 1
• Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis PatientsCompletedNCT01870908
• A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)CompletedNCT01870895Phase 3
• A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAFCompletedNCT01839929Phase 4
• A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy SubjectsCompletedNCT01815684Phase 1
• Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male SubjectsCompletedNCT01813461Phase 1
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian SubjectsCompletedNCT01813448Phase 1
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy SubjectsCompletedNCT01809860Phase 1
• Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome)CompletedNCT01799902
• A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy SubjectsCompletedNCT01797198Phase 1
• Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer PatientsCompletedNCT01793077
• A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsCompletedNCT01780844Phase 2
• A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune SystemTerminatedNCT01775397Phase 4
• A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic PainCompletedNCT01767090Phase 2
• A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeCompletedNCT01763580Phase 4
• A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT01754805Phase 1
• Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)CompletedNCT01747577Phase 4
• A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese SubjectsCompletedNCT01747564Phase 1
• Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
• A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal RecipientsCompletedNCT01742676Phase 4
• Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the TransplantationCompletedNCT01742624Phase 4
• Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742611Phase 3
• A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742585Phase 3
• Observation of the Use of QUTENZA™ in Standard Clinical PracticeCompletedNCT01737294
• A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With GoutCompletedNCT01736514Phase 3
• A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT01736423Phase 3
• Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese VolunteersCompletedNCT01720212Phase 1
• A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeCompletedNCT01714843Phase 2
• A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of TreatmentCompletedNCT01713426Phase 4
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult SubjectsCompletedNCT01711827Phase 1
• A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis StudyCompletedNCT01711814Phase 2
• A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult SubjectsCompletedNCT01711489Phase 1
• A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic MalignanciesTerminatedNCT01705483Phase 1
• Short and Long-term Safety of Micafungin and Other Parenteral Antifungal AgentsCompletedNCT01686607
• A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015KCompletedNCT01686217Phase 1
• A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male VolunteersCompletedNCT01681134Phase 1
• Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy AdultsCompletedNCT01678287Phase 1
• A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy VolunteersCompletedNCT01675518Phase 1
• A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941CompletedNCT01674777Phase 1
• A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary HistologyCompletedNCT01672775Phase 1
• A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes PatientsCompletedNCT01672762Phase 3
• Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric CancerCompletedNCT01671774Phase 1
• A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178CompletedNCT01663961Phase 1
• A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerWithdrawnNCT01663415Phase 2
• Drug-drug Interaction Study Between Lopinavir/Ritonavir and IsavuconazoleCompletedNCT01660477Phase 1
• A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male SubjectsCompletedNCT01657981Phase 1
• Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female SubjectsCompletedNCT01657890Phase 1
• Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult SubjectsCompletedNCT01657838Phase 1
• Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male SubjectsCompletedNCT01657825Phase 1
• A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the BodyCompletedNCT01655056Phase 1
• Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult SubjectsCompletedNCT01651325Phase 1
• A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178CompletedNCT01651312Phase 1
• A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis SubjectsCompletedNCT01649999Phase 2
• A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted ConditionsCompletedNCT01646294Phase 1
• Vesitirim™ in Men Postmarketing Observational StudyCompletedNCT01639794
• Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of BupropionCompletedNCT01635972Phase 1
• Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of AtorvastatinCompletedNCT01635946Phase 1
• Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerCompletedNCT01630083Phase 2
• A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of TimeCompletedNCT01614665Phase 2
• A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)CompletedNCT01613586Phase 2
• Absolute Bioavailability Study With IpragliflozinCompletedNCT01611428Phase 1
• Drug to Drug Interaction Study With Ipragliflozin and FurosemideCompletedNCT01611415Phase 1
• A Phase 1 Study to Investigate the Mechanism of Action of IpragliflozinCompletedNCT01611363Phase 1
• A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002CompletedNCT01608711Phase 2
• Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyApproved for marketingNCT01606982
• Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive BladderCompletedNCT01604928Phase 2
• Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and NorethindroneCompletedNCT01597986Phase 1
• A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT01585233Phase 2
• Drug Interaction Study of Isavuconazole and MethadoneCompletedNCT01582425Phase 1
• Drug Interaction Study of Isavuconazole and DigoxinCompletedNCT01582412Phase 1
• Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240CompletedNCT01582399Phase 1
• A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy SubjectsCompletedNCT01579461Phase 1
• Study of the Effect of Repeat Doses of Isavuconazole on Cardiac RepolarizationCompletedNCT01565720Phase 1
• Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy SubjectsCompletedNCT01565681Phase 1
• A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid ArthritisCompletedNCT01565655Phase 2

← Astellas Pharma Inc overview and focus areas